ACS Medicinal Chemistry Letters
Letter
Skeleton Derived from Thalidomide-Related Glucosidase Inhibitors.
Bioorg. Med. Chem. Lett. 2007, 17, 3957−3961.
(28) Kawai, T.; Akira, S. TLR Signaling. Cell Death Differ. 2006, 13,
(13) Zuercher, W. J.; Buckholz, R. G.; Campobasso, N.; Collins, J. L.;
Galardi, C. M.; Gampe, R. T.; Hyatt, S. M.; Merrihew, S. L.; Moore, J.
T.; Oplinger, J. A.; et al. Discovery of Tertiary Sulfonamides as Potent
Liver X Receptor Antagonists. J. Med. Chem. 2010, 53, 3412−3416.
(14) Jiao, X.; Kopecky, D. J.; Fisher, B.; Piper, D. E.; Labelle, M.;
McKendry, S.; Harrison, M.; Jones, S.; Jaen, J.; Shiau, A. K.; et al.
Discovery and Optimization of a Series of Liver X Receptor
Antagonists. Bioorg. Med. Chem. Lett. 2012, 22, 5966−5970.
(15) Joseph, S. B.; Bradley, M. N.; Castrillo, A.; Bruhn, K. W.; Mak,
P. A.; Pei, L.; Hogenesch, J.; O’connell, R. M.; Cheng, G.; Saez, E.;
et al. LXR-Dependent Gene Expression Is Important for Macrophage
Survival and the Innate Immune Response. Cell 2004, 119, 299−309.
(16) Joseph, S. B.; Castrillo, A.; Laffitte, B. A.; Mangelsdorf, D. J.;
Tontonoz, P. Reciprocal Regulation of Inflammation and Lipid
Metabolism by Liver X Receptors. Nat. Med. 2003, 9, 213−219.
(17) Glass, C. K.; Saijo, K. Nuclear Receptor Transrepression
Pathways That Regulate Inflammation in Macrophages and T Cells.
Nat. Rev. Immunol. 2010, 10, 365−376.
(29) Mali, P.; Yang, L.; Esvelt, K. M.; Aach, J.; Guell, M.; DiCarlo, J.
E.; Norville, J. E.; Church, G. M. RNA-Guided Human Genome
Engineering via Cas9. Science 2013, 339, 823−826.
(30) Fradera, X.; Vu, D.; Nimz, O.; Skene, R.; Hosfield, D.; Wynands,
R.; Cooke, A. J.; Haunsø, A.; King, A.; Bennett, D. J.; et al. X-Ray
Structures of the LXRα LBD in Its Homodimeric Form and
Implications for Heterodimer Signaling. J. Mol. Biol. 2010, 399,
̈
(31) Svensson, S.; Ostberg, T.; Jacobsson, M.; Norstrom, C.;
̈
́
Stefansson, K.; Hallen, D.; Johansson, I. C.; Zachrisson, K.; Ogg, D.;
Jendeberg, L. Crystal Structure of the Heterodimeric Complex of
LXRα and RXRβ Ligand-Binding Domains in a Fully Agonistic
Conformation. EMBO J. 2003, 22, 4625−4633.
(32) Williams, S.; Bledsoe, R. K.; Collins, J. L.; Boggs, S.; Lambert,
M. H.; Miller, A. B.; Moore, J.; McKee, D. D.; Moore, L.; Nichols, J.;
et al. X-Ray Crystal Structure of the Liver X Receptor Beta Ligand
Binding Domain: Regulation by a Histidine-Tryptophan Switch. J. Biol.
(18) Ghisletti, S.; Huang, W.; Ogawa, S.; Pascual, G.; Lin, M.-E.;
Willson, T. M.; Rosenfeld, M. G.; Glass, C. K. Parallel SUMOylation-
Dependent Pathways Mediate Gene- and Signal-Specific Trans-
repression by LXRs and PPARgamma. Mol. Cell 2007, 25, 57−70.
(19) Fowler, A. J.; Sheu, M. Y.; Schmuth, M.; Kao, J.; Fluhr, J. W.;
Rhein, L.; Collins, J. L.; Willson, T. M.; Mangelsdorf, D. J.; Elias, P.
M.; et al. Liver X Receptor Activators Display Anti-Inflammatory
Activity in Irritant and Allergic Contact Dermatitis Models: Liver-X-
Receptor-Specific Inhibition of Inflammation and Primary Cytokine
Production. J. Invest. Dermatol. 2003, 120, 246−255.
(20) Asquith, D. L.; Miller, A. M.; Hueber, A. J.; McKinnon, H. J.;
Sattar, N.; Graham, G. J.; McInnes, I. B. Liver X Receptor Agonism
Promotes Articular Inflammation in Murine Collagen-Induced
Arthritis. Arthritis Rheum. 2009, 60, 2655−2665.
(21) Wang, Y. Y.; Ryg, U.; Dahle, M. K.; Steffensen, K. R.;
Thiemermann, C.; Chaudry, I. H.; Reinholt, F. P.; Collins, J. L.; Nebb,
H. I.; Aasen, A. O.; et al. Liver X Receptor Protects against Liver Injury
in Sepsis Caused by Rodent Cecal Ligation and Puncture. Surg. Infect.
(Larchmt). 2011, 12, 283−289.
(22) Wang, Y. Y.; Dahle, M. K.; Agren, J.; Myhre, A. E.; Reinholt, F.
P.; Foster, S. J.; Collins, J. L.; Thiemermann, C.; Aasen, A. O.; Wang, J.
E. Activation of the Liver X Receptor Protects against Hepatic Injury
in Endotoxemia by Suppressing Kupffer Cell Activation. Shock 2006,
(23) Chao, E. Y.; Caravella, J. A.; Watson, M. A.; Campobasso, N.;
Ghisletti, S.; Billin, A. N.; Galardi, C.; Wang, P.; Laffitte, B. A.;
Iannone, M. A.; et al. Structure-Guided Design of N-Phenyl Tertiary
Amines as Transrepression-Selective Liver X Receptor Modulators
with Anti-Inflammatory Activity. J. Med. Chem. 2008, 51, 5758−5765.
(24) Aoyama, A.; Endo-Umeda, K.; Kishida, K.; Ohgane, K.;
Noguchi-Yachide, T.; Aoyama, H.; Ishikawa, M.; Miyachi, H.;
Makishima, M.; Hashimoto, Y. Design, Synthesis, and Biological
Evaluation of Novel Transrepression-Selective Liver X Receptor
(LXR) Ligands with 5,11-Dihydro-5-Methyl-11-Methylene-6H-
Dibenz[b,e]azepin-6-One Skeleton. J. Med. Chem. 2012, 55, 7360−
(25) Whitney, K. D.; Watson, M. A.; Goodwin, B.; Galardi, C. M.;
Maglich, J. M.; Wilson, J. G.; Willson, T. M.; Collins, J. L.; Kliewer, S.
A. Liver X Receptor (LXR) Regulation of the LXRα Gene in Human
Macrophages. J. Biol. Chem. 2001, 276, 43509−43515.
(26) Jaye, M. C.; Krawiec, J. A.; Campobasso, N.; Smallwood, A.;
Qiu, C.; Lu, Q.; Kerrigan, J. J.; Alvaro, M. D. L. F.; Laffitte, B.; Liu, W.;
et al. Discovery of Substituted Maleimides as Liver X Receptor
Agonists and Determination of a Ligand-Bound Crystal Structure. J.
Med. Chem. 2005, 48, 5419−5422.
(27) Molteni, V.; Li, X.; Nabakka, J.; Liang, F.; Wityak, J.; Koder, A.;
Vargas, L.; Romeo, R.; Mitro, N.; Mak, P. A.; et al. N-Acylthiadiazo-
lines, a New Class of Liver X Receptor Agonists with Selectivity for
LXRbeta. J. Med. Chem. 2007, 50, 4255−4259.
F
ACS Med. Chem. Lett. XXXX, XXX, XXX−XXX